Status:
NOT_YET_RECRUITING
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Eligibility:
FEMALE
20+ years
Brief Summary
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Eligibility Criteria
Inclusion
- women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy
Exclusion
- women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)
Key Trial Info
Start Date :
August 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06535334
Start Date
August 15 2024
End Date
May 1 2026
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050